Robert Regenhardt, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Ischemia | 31 | 2024 | 3265 | 4.750 |
Why?
|
Endovascular Procedures | 32 | 2024 | 1980 | 4.700 |
Why?
|
Stroke | 52 | 2024 | 9981 | 4.220 |
Why?
|
Thrombectomy | 28 | 2024 | 680 | 3.770 |
Why?
|
Embolization, Therapeutic | 19 | 2024 | 1392 | 2.260 |
Why?
|
Arterial Occlusive Diseases | 4 | 2023 | 793 | 1.990 |
Why?
|
Intracranial Aneurysm | 16 | 2024 | 1197 | 1.770 |
Why?
|
Angiotensin I | 5 | 2015 | 57 | 1.620 |
Why?
|
Vascular System Injuries | 3 | 2023 | 250 | 1.550 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2023 | 90 | 0.950 |
Why?
|
Cerebral Amyloid Angiopathy | 5 | 2023 | 859 | 0.930 |
Why?
|
Cerebral Infarction | 8 | 2022 | 1011 | 0.860 |
Why?
|
Cerebral Angiography | 6 | 2023 | 1285 | 0.820 |
Why?
|
Mucopolysaccharidosis II | 1 | 2021 | 27 | 0.820 |
Why?
|
Aneurysm, Ruptured | 6 | 2023 | 452 | 0.770 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2021 | 114 | 0.750 |
Why?
|
Vertebral Artery | 1 | 2021 | 192 | 0.750 |
Why?
|
Treatment Outcome | 46 | 2024 | 63107 | 0.730 |
Why?
|
Brain Infarction | 2 | 2020 | 299 | 0.680 |
Why?
|
Peptide Fragments | 6 | 2015 | 5096 | 0.680 |
Why?
|
Endothelin-1 | 5 | 2015 | 314 | 0.640 |
Why?
|
Reperfusion | 5 | 2022 | 284 | 0.630 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 238 | 0.620 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2015 | 475 | 0.620 |
Why?
|
Cerebral Arteries | 1 | 2019 | 494 | 0.570 |
Why?
|
Thrombolytic Therapy | 7 | 2023 | 2162 | 0.560 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2021 | 2737 | 0.520 |
Why?
|
Nerve Regeneration | 1 | 2020 | 788 | 0.470 |
Why?
|
Endocarditis | 3 | 2022 | 349 | 0.470 |
Why?
|
Retrospective Studies | 38 | 2024 | 77460 | 0.450 |
Why?
|
Patient Transfer | 3 | 2021 | 762 | 0.440 |
Why?
|
Fibrinolytic Agents | 6 | 2023 | 2158 | 0.440 |
Why?
|
Carotid-Cavernous Sinus Fistula | 2 | 2023 | 40 | 0.430 |
Why?
|
Middle Cerebral Artery | 2 | 2013 | 264 | 0.420 |
Why?
|
Siderosis | 2 | 2023 | 102 | 0.400 |
Why?
|
Recovery of Function | 3 | 2020 | 2926 | 0.390 |
Why?
|
Neuroprotective Agents | 3 | 2015 | 941 | 0.380 |
Why?
|
Receptors, G-Protein-Coupled | 4 | 2015 | 1222 | 0.380 |
Why?
|
Peptidyl-Dipeptidase A | 4 | 2016 | 365 | 0.370 |
Why?
|
Renin-Angiotensin System | 2 | 2015 | 758 | 0.360 |
Why?
|
Humans | 89 | 2024 | 744366 | 0.360 |
Why?
|
Vasodilator Agents | 1 | 2014 | 976 | 0.340 |
Why?
|
Collateral Circulation | 2 | 2021 | 287 | 0.330 |
Why?
|
Skull | 1 | 2013 | 814 | 0.320 |
Why?
|
Endocarditis, Bacterial | 2 | 2022 | 455 | 0.310 |
Why?
|
Microglia | 2 | 2013 | 1267 | 0.310 |
Why?
|
Aged | 27 | 2024 | 163288 | 0.300 |
Why?
|
Cerebral Hemorrhage | 10 | 2023 | 2647 | 0.300 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 4153 | 0.300 |
Why?
|
Stents | 10 | 2024 | 3282 | 0.300 |
Why?
|
Middle Aged | 35 | 2023 | 213390 | 0.290 |
Why?
|
Decompression, Surgical | 2 | 2021 | 594 | 0.270 |
Why?
|
Male | 43 | 2024 | 350115 | 0.270 |
Why?
|
Proto-Oncogene Proteins | 4 | 2015 | 4554 | 0.270 |
Why?
|
Meningeal Arteries | 2 | 2023 | 61 | 0.260 |
Why?
|
Aged, 80 and over | 15 | 2024 | 57776 | 0.250 |
Why?
|
Time Factors | 6 | 2021 | 40075 | 0.250 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2023 | 1018 | 0.250 |
Why?
|
Infarction | 2 | 2023 | 244 | 0.250 |
Why?
|
Female | 39 | 2024 | 380193 | 0.250 |
Why?
|
Magnetic Resonance Imaging | 11 | 2023 | 35425 | 0.240 |
Why?
|
Carotid Stenosis | 2 | 2022 | 854 | 0.240 |
Why?
|
Brain | 4 | 2022 | 26388 | 0.230 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1261 | 0.220 |
Why?
|
Intracranial Hemorrhages | 4 | 2023 | 855 | 0.220 |
Why?
|
Hypertension | 3 | 2023 | 8479 | 0.220 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.220 |
Why?
|
Cerebrovascular Trauma | 1 | 2022 | 23 | 0.220 |
Why?
|
Cerebrovascular Circulation | 5 | 2022 | 2732 | 0.210 |
Why?
|
Bayes Theorem | 4 | 2022 | 2307 | 0.200 |
Why?
|
Aneurysm, Infected | 1 | 2022 | 85 | 0.200 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1622 | 0.200 |
Why?
|
Perfusion Imaging | 1 | 2023 | 195 | 0.200 |
Why?
|
Peptides | 1 | 2014 | 4410 | 0.200 |
Why?
|
Cavernous Sinus | 1 | 2022 | 125 | 0.200 |
Why?
|
Basilar Artery | 1 | 2022 | 200 | 0.200 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2021 | 53 | 0.200 |
Why?
|
Leukoaraiosis | 1 | 2022 | 120 | 0.190 |
Why?
|
Carotid Artery, Internal, Dissection | 1 | 2020 | 45 | 0.190 |
Why?
|
Cerebral Cortex | 2 | 2015 | 5709 | 0.180 |
Why?
|
Cohort Studies | 9 | 2024 | 40559 | 0.180 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2020 | 138 | 0.170 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2021 | 145 | 0.170 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 208 | 0.170 |
Why?
|
Paralysis | 1 | 2020 | 247 | 0.170 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2021 | 257 | 0.170 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2022 | 356 | 0.170 |
Why?
|
Arteriovenous Fistula | 1 | 2022 | 315 | 0.170 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2020 | 292 | 0.160 |
Why?
|
Intracranial Embolism | 1 | 2020 | 202 | 0.160 |
Why?
|
Perfusion | 1 | 2023 | 1360 | 0.160 |
Why?
|
Diminazene | 2 | 2015 | 3 | 0.160 |
Why?
|
Corpus Striatum | 2 | 2015 | 1221 | 0.160 |
Why?
|
Rats, Sprague-Dawley | 6 | 2015 | 8300 | 0.150 |
Why?
|
Tanzania | 2 | 2019 | 1346 | 0.150 |
Why?
|
Infusions, Intraventricular | 2 | 2015 | 36 | 0.150 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 546 | 0.150 |
Why?
|
Nitric Oxide Synthase Type II | 3 | 2014 | 534 | 0.150 |
Why?
|
Informed Consent | 1 | 2023 | 995 | 0.150 |
Why?
|
Rats | 7 | 2015 | 24252 | 0.140 |
Why?
|
History, 19th Century | 1 | 2019 | 720 | 0.140 |
Why?
|
Head | 1 | 2022 | 880 | 0.140 |
Why?
|
Prospective Studies | 7 | 2023 | 53290 | 0.140 |
Why?
|
Brain Stem | 1 | 2021 | 846 | 0.130 |
Why?
|
Carotid Artery Diseases | 1 | 2022 | 879 | 0.130 |
Why?
|
Thalamus | 1 | 2021 | 1023 | 0.130 |
Why?
|
Disease Progression | 3 | 2022 | 13286 | 0.130 |
Why?
|
Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 10 | 0.120 |
Why?
|
Robotics | 1 | 2022 | 899 | 0.120 |
Why?
|
Triage | 2 | 2021 | 977 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2022 | 1074 | 0.120 |
Why?
|
Cervical Vertebrae | 1 | 2020 | 976 | 0.120 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 15078 | 0.120 |
Why?
|
Spine | 1 | 2021 | 1144 | 0.120 |
Why?
|
Rats, Inbred SHR | 1 | 2013 | 195 | 0.120 |
Why?
|
Deglutition Disorders | 1 | 2019 | 606 | 0.110 |
Why?
|
Databases, Factual | 4 | 2021 | 7730 | 0.110 |
Why?
|
Staphylococcal Infections | 1 | 2022 | 1400 | 0.110 |
Why?
|
Neurogenesis | 1 | 2020 | 838 | 0.110 |
Why?
|
History, 21st Century | 1 | 2019 | 1534 | 0.110 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2013 | 226 | 0.110 |
Why?
|
Animals | 13 | 2022 | 168768 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1563 | 0.110 |
Why?
|
Corticosterone | 1 | 2013 | 310 | 0.110 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2013 | 242 | 0.110 |
Why?
|
Neurosurgical Procedures | 2 | 2022 | 2002 | 0.110 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.100 |
Why?
|
Disability Evaluation | 1 | 2019 | 1828 | 0.100 |
Why?
|
Risk Factors | 8 | 2022 | 72296 | 0.100 |
Why?
|
Aspirin | 2 | 2023 | 3283 | 0.100 |
Why?
|
Angiography, Digital Subtraction | 2 | 2023 | 341 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2740 | 0.100 |
Why?
|
Urban Population | 1 | 2019 | 2022 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2021 | 2585 | 0.090 |
Why?
|
Brain Injuries | 1 | 2022 | 2029 | 0.090 |
Why?
|
Mice, Inbred Strains | 1 | 2013 | 1828 | 0.090 |
Why?
|
Retreatment | 2 | 2022 | 610 | 0.090 |
Why?
|
Disabled Persons | 1 | 2020 | 1212 | 0.090 |
Why?
|
Patient Selection | 1 | 2022 | 4216 | 0.090 |
Why?
|
Patient Admission | 1 | 2017 | 1380 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2047 | 0.090 |
Why?
|
alpha-Synuclein | 1 | 2014 | 722 | 0.080 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18034 | 0.080 |
Why?
|
Biopsy | 1 | 2019 | 6755 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2022 | 3537 | 0.070 |
Why?
|
Dementia | 1 | 2021 | 2518 | 0.070 |
Why?
|
Central Nervous System | 1 | 2014 | 1357 | 0.070 |
Why?
|
Palliative Care | 1 | 2021 | 3493 | 0.070 |
Why?
|
Administration, Oral | 2 | 2023 | 3914 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5035 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2013 | 2132 | 0.060 |
Why?
|
Motor Activity | 1 | 2014 | 2715 | 0.060 |
Why?
|
Phenotype | 2 | 2019 | 16367 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15535 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
Anterior Cerebral Artery | 1 | 2023 | 48 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20130 | 0.060 |
Why?
|
Anticoagulants | 3 | 2023 | 4600 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4567 | 0.050 |
Why?
|
Body Weight | 1 | 2013 | 4671 | 0.050 |
Why?
|
Prognosis | 2 | 2020 | 29060 | 0.050 |
Why?
|
Postoperative Complications | 2 | 2022 | 15297 | 0.050 |
Why?
|
Blood Pressure | 2 | 2016 | 8551 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5321 | 0.050 |
Why?
|
Circle of Willis | 1 | 2021 | 68 | 0.050 |
Why?
|
Learning Curve | 1 | 2022 | 208 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10637 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8385 | 0.050 |
Why?
|
Heart | 1 | 2013 | 4464 | 0.050 |
Why?
|
Angiotensin II | 2 | 2015 | 881 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2013 | 4463 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2023 | 3070 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23336 | 0.040 |
Why?
|
Patient Rights | 1 | 2020 | 126 | 0.040 |
Why?
|
Diskectomy | 1 | 2020 | 206 | 0.040 |
Why?
|
Cerebral Revascularization | 1 | 2021 | 238 | 0.040 |
Why?
|
Bioethical Issues | 1 | 2020 | 124 | 0.040 |
Why?
|
Depression | 1 | 2018 | 7759 | 0.040 |
Why?
|
Imidazoles | 2 | 2015 | 1206 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2013 | 14561 | 0.040 |
Why?
|
Kidney | 1 | 2013 | 7184 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 857 | 0.040 |
Why?
|
Craniotomy | 1 | 2022 | 729 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2022 | 737 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2022 | 934 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.040 |
Why?
|
Heart Atria | 1 | 2023 | 1356 | 0.040 |
Why?
|
Propensity Score | 1 | 2024 | 1781 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 19233 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2015 | 3702 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1677 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2065 | 0.030 |
Why?
|
Adult | 7 | 2023 | 214052 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12073 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2020 | 935 | 0.030 |
Why?
|
Lymphocytes | 1 | 2022 | 2617 | 0.030 |
Why?
|
Models, Neurological | 1 | 2022 | 1775 | 0.030 |
Why?
|
Systole | 1 | 2016 | 958 | 0.030 |
Why?
|
ADAM Proteins | 1 | 2015 | 243 | 0.030 |
Why?
|
Leucine | 1 | 2015 | 560 | 0.030 |
Why?
|
Reoperation | 1 | 2023 | 4201 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2014 | 552 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1099 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2014 | 529 | 0.030 |
Why?
|
Radiographic Image Enhancement | 1 | 2017 | 885 | 0.030 |
Why?
|
Swine | 1 | 2022 | 5918 | 0.030 |
Why?
|
Spinal Fusion | 1 | 2020 | 1241 | 0.020 |
Why?
|
Peroxidase | 1 | 2014 | 611 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2428 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3721 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2859 | 0.020 |
Why?
|
Mice | 2 | 2014 | 81201 | 0.020 |
Why?
|
Thiophenes | 1 | 2014 | 589 | 0.020 |
Why?
|
Social Support | 1 | 2018 | 2118 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10400 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3954 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5953 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12961 | 0.020 |
Why?
|
Brain Mapping | 1 | 2021 | 6670 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3154 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18373 | 0.020 |
Why?
|
Sulfonamides | 1 | 2014 | 1940 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7914 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2825 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9735 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25039 | 0.010 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39052 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13035 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7323 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2014 | 21833 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
United States | 1 | 2021 | 69872 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23404 | 0.010 |
Why?
|